We are committed to the development of vehicles to safely and effectively administer therapeutic agents and to pursue new and improved disease detection technologies. To this end, we are currently pursuing research into ROMP-based polymer nanoparticles, polymer-caged liposomes, ROMP-based DNA detection, and fundamental DNA interactions.